Evidence map›Paper›PMID 39616361›Full record

ArticleBMC health services research2024

Revealing disparities in representation in knowledge generation and guideline development.

Carlos P B Almeida, Afom T Andom, Alain Casseus, Jacquelyn-My Do, Alain Gelin, Leonid Lecca, Maxo Luma, Michael Mazzi, Carole D Mitnick, Jean Claude Mugunga and 7 more

Abstract read
In one paragraph

Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Carlos P B AlmeidaUniversidade Federal Do Sul E Sudeste Do Pará, Marabá, Brazil.
Afom T AndomPartners In Health Lesotho, Maseru, Lesotho.
Alain CasseusPartners In Health, Boston, USA.
Jacquelyn-My DoHarvard Medical School, Boston, USA.
Alain GelinPartners In Health, Boston, USA.
Leonid LeccaHarvard Medical School, Boston, USA.
Maxo LumaPartners In Health, Boston, USA.
Michael MazziPartners In Health, Boston, USA.
Carole D MitnickHarvard Medical School, Boston, USA. carole_mitnick@hms.harvard.edu.
Jean Claude MugungaPartners In Health, Boston, USA.
Melino NdayizigiyePartners In Health Lesotho, Maseru, Lesotho.
Natalie NguyenCornell University, Ithaca, USA.
Meseret TamiratPartners In Health Lesotho, Maseru, Lesotho.
Girum TeferaPartners In Health, Boston, USA.
Sterman ToussaintPartners In Health, Boston, USA.
Marco TovarInsitituto de Investigación Nutriciona, Lima, Peru.
Christine TzeliosHarvard Medical School, Boston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultidrug-resistant tuberculosis (MDR/RR-TB) is a major global health challenge, disproportionately affecting low- and lower-middle-income countries (LLMICs). The World Health Organization (WHO) generates guidance to address the problem. Here, we explore the extent to which guidance and related knowledge are generated by experts living in the most-affected countries and consider the results in the context of the movement to decolonize global health.

methodsWe examined the composition of World Health Organization (WHO) MDR/RR-TB treatment Guideline Development Groups (GDGs) from 2016 to 2022. We classified GDG members according to the MDR/RR-TB burden and World Bank income level of the country of their institutional affiliation. We also searched PubMed to identify peer-reviewed publications from 2016 to 2023 which emanated from individual-patient-data meta-analysis like those done for Guideline review, and classified the publication authors according to the same indicators.

resultsThere were 33 high-burden MDR/RR-TB countries during the time period. Of these, 72.1% were LLMICs and none was high-income. In contrast, only 30.3% of WHO GDG members and 10.4% of peer-reviewed publication authors were from LLMICs. Representatives from high-MDR/RR-TB-burden countries comprised 34.3% of WHO GDG members and 14.7% of authors of guideline-related publications.

conclusionsThe important imbalance between the geographical distribution of lived experience with MDR/RR-TB and the distribution of individuals generating knowledge and guidance on treatment of MDR/RR-TB can have clinical and resource implications. Countries may reject or defer guideline adoption because of a mismatch between that guidance and local disease epidemiology. Funding conditioned on compliance with guidelines can exacerbate health inequalities. The movement to decolonize global health considers representation disparities as epistemic injustice, that is unfair treatment in the process of generating, sharing, or receiving knowledge. Reform is possible in many of the institutions involved in generation of global health knowledge, such as: meaningful participation of LLMICs in projects as a requirement for research funding, improved attention to the epistemic and geographical location of journal editorial staff, and broader inclusion in guidelines committees. Better alignment of participation in knowledge generation with burden of disease holds potential for reducing inequality and improving relevance of guidance for the lived experience with MDR/RR-TB.

Indexed as

Global HealthPractice Guidelines as TopicTuberculosis, Multidrug-ResistantWorld Health OrganizationDeveloping CountriesHumansDecolonizationEpistemic injusticeGlobal health disparitiesGuideline developmentMultidrug-resistant tuberculosis

Identifiers

PMID39616361
PMCPMC11607871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.